CN100393694C - 四苄基伏格列波糖的结晶及制备方法 - Google Patents

四苄基伏格列波糖的结晶及制备方法 Download PDF

Info

Publication number
CN100393694C
CN100393694C CNB2006100617134A CN200610061713A CN100393694C CN 100393694 C CN100393694 C CN 100393694C CN B2006100617134 A CNB2006100617134 A CN B2006100617134A CN 200610061713 A CN200610061713 A CN 200610061713A CN 100393694 C CN100393694 C CN 100393694C
Authority
CN
China
Prior art keywords
preparation
voglibose
tetrabenzyl
tetrabenzyl voglibose
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100617134A
Other languages
English (en)
Chinese (zh)
Other versions
CN1931826A (zh
Inventor
刘立刚
李瑞文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaxyn Lab Ltd.
Original Assignee
YAOXING BIOLOGICAL SCI-TECH DEVELOPMENT Co Ltd SHENZHEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37877872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN100393694(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by YAOXING BIOLOGICAL SCI-TECH DEVELOPMENT Co Ltd SHENZHEN filed Critical YAOXING BIOLOGICAL SCI-TECH DEVELOPMENT Co Ltd SHENZHEN
Priority to CNB2006100617134A priority Critical patent/CN100393694C/zh
Publication of CN1931826A publication Critical patent/CN1931826A/zh
Priority to CA002654424A priority patent/CA2654424A1/en
Priority to PCT/CN2007/001902 priority patent/WO2008011791A1/zh
Priority to KR1020087031619A priority patent/KR101379988B1/ko
Priority to JP2009519780A priority patent/JP5216006B2/ja
Application granted granted Critical
Publication of CN100393694C publication Critical patent/CN100393694C/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB2006100617134A 2006-07-17 2006-07-17 四苄基伏格列波糖的结晶及制备方法 Expired - Fee Related CN100393694C (zh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CNB2006100617134A CN100393694C (zh) 2006-07-17 2006-07-17 四苄基伏格列波糖的结晶及制备方法
CA002654424A CA2654424A1 (en) 2006-07-17 2007-06-18 Tetra-benzyl voglibose in crystalline form and a method for preparing the same
PCT/CN2007/001902 WO2008011791A1 (fr) 2006-07-17 2007-06-18 Voglibose tetrabenzyle cristallin et procédé de préparation associé
KR1020087031619A KR101379988B1 (ko) 2006-07-17 2007-06-18 결정상의 테트라벤질 보글리보스 및 그의 제조방법
JP2009519780A JP5216006B2 (ja) 2006-07-17 2007-06-18 結晶型テトラベンジルボグリボース及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100617134A CN100393694C (zh) 2006-07-17 2006-07-17 四苄基伏格列波糖的结晶及制备方法

Publications (2)

Publication Number Publication Date
CN1931826A CN1931826A (zh) 2007-03-21
CN100393694C true CN100393694C (zh) 2008-06-11

Family

ID=37877872

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100617134A Expired - Fee Related CN100393694C (zh) 2006-07-17 2006-07-17 四苄基伏格列波糖的结晶及制备方法

Country Status (5)

Country Link
JP (1) JP5216006B2 (ko)
KR (1) KR101379988B1 (ko)
CN (1) CN100393694C (ko)
CA (1) CA2654424A1 (ko)
WO (1) WO2008011791A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393694C (zh) * 2006-07-17 2008-06-11 深圳市药兴生物科技开发有限公司 四苄基伏格列波糖的结晶及制备方法
US10586702B2 (en) * 2015-08-07 2020-03-10 North Carolina State University Synthesis and processing of novel phase of carbon (Q-carbon)
CN105254514B (zh) * 2015-11-12 2017-09-05 重庆植恩药业有限公司 一种四苄基伏格列波糖的制备方法
CN110317142B (zh) * 2019-07-18 2023-03-28 植恩生物技术股份有限公司 一种伏格列波糖的制备方法
CN113214094A (zh) * 2021-04-26 2021-08-06 潍坊天福化学科技有限公司 一种伏格列波糖的合成方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030698A1 (en) * 2003-09-26 2005-04-07 Ranbaxy Laboratories Limited Process for the preparation of voglibose
WO2005049574A1 (en) * 2003-11-20 2005-06-02 Warner-Lambert Company Llc Androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205455A (ja) * 1985-03-11 1986-09-11 Takeda Chem Ind Ltd 低カロリ−砂糖含有組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
JP2003034655A (ja) * 2001-05-15 2003-02-07 Takeda Chem Ind Ltd 速崩壊性固形製剤
JP4408340B2 (ja) * 2002-03-22 2010-02-03 武田薬品工業株式会社 速崩壊性固形製剤
WO2005049547A1 (en) 2003-11-21 2005-06-02 Ranbaxy Laboratories Limited Process for the preparation of 1,2,3,4-cyclohexanetetrol derivatives
CN100393694C (zh) * 2006-07-17 2008-06-11 深圳市药兴生物科技开发有限公司 四苄基伏格列波糖的结晶及制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030698A1 (en) * 2003-09-26 2005-04-07 Ranbaxy Laboratories Limited Process for the preparation of voglibose
WO2005049574A1 (en) * 2003-11-20 2005-06-02 Warner-Lambert Company Llc Androgen receptor modulators

Also Published As

Publication number Publication date
WO2008011791A1 (fr) 2008-01-31
CN1931826A (zh) 2007-03-21
KR101379988B1 (ko) 2014-04-01
CA2654424A1 (en) 2008-01-31
JP5216006B2 (ja) 2013-06-19
KR20090031376A (ko) 2009-03-25
JP2009543814A (ja) 2009-12-10

Similar Documents

Publication Publication Date Title
CN112876454A (zh) 一种人工合成（r，s)-尼古丁盐的制备方法
CN100393694C (zh) 四苄基伏格列波糖的结晶及制备方法
RU2010133160A (ru) Способ синтеза тетрагидробиоптерина
CN101863948B (zh) 高纯度(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇或其组合物及其制备方法
WO2013111162A2 (en) Process for preparation of fingolimod
CN103242193B (zh) 一种羟肟化杯[6]芳烃高效铀萃取剂的制备及其用途
CN102020554A (zh) 一种2-[4-(羟基苯氧基)]丙酸的合成方法
CN103360374A (zh) 维拉唑酮及其盐的合成方法
CN101279925B (zh) 四苄基伏格列波糖盐及其制备方法和应用
CN103073446B (zh) 盐酸伊托必利的制备方法
CN114539077B (zh) 一种盐酸左沙丁胺醇的合成方法
CN104961787B (zh) 一种虫草素的合成方法
CN109912512B (zh) 一种新的替米沙坦杂质化合物及其制备方法和用途
CN107715909B (zh) 一种季戊四醇支载的脯氨酸催化剂及其制备方法及应用
CN106083689B (zh) 一种赛洛多辛化合物的制备方法
CN105431409A (zh) 制备阿福特罗或其盐的方法
CN105884625B (zh) 一种r-沙美特罗的合成方法
CN110804022B (zh) 一种右丙亚胺的制备方法
CN106957235B (zh) 一种他莫昔芬的制备方法
CN102260236B (zh) 一种香豆素类化合物的制备方法
CN105732466A (zh) 一种4-羟基苯基双吲哚甲烷的制备方法
CN114605241B (zh) 一种盐酸艾司氯胺酮中间体的制备方法及其中间体
CN109384737A (zh) 一种四氮杂环钇络合物及其制备方法和应用
CN106146424A (zh) 一种5-甲基-3,4-二苯基异噁唑的制备方法
CN108530375B (zh) 4-氧杂-7-氮杂螺[2.5]辛烷或其盐的中间体及制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20081205

Address after: Jiangsu city of Wuxi province Jiangyin Qingyang China Zhen Min Pu Lu No. 9

Patentee after: Pharmaxyn Lab Ltd.

Address before: Guangdong Province, Shenzhen City, Nanshan District South Road Nanyuan Village East Room 3-101

Patentee before: Yaoxing Biological Sci-Tech Development Co., Ltd., Shenzhen

ASS Succession or assignment of patent right

Owner name: WUXI YAOXING PHARMACEUTICAL TECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: SHENZHEN CITY YAOXING BIOLOGICAL TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20081205

C35 Partial or whole invalidation of patent or utility model
IW01 Full invalidation of patent right

Decision date of declaring invalidation: 20090831

Decision number of declaring invalidation: 13740

Granted publication date: 20080611

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080611

Termination date: 20110717